The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Duck Vaccines Market Research Report 2024
Synopsis
Vaccination is commonly used in commercial duck and increasingly in backyard birds to control disease.
The global Duck Vaccines market was valued at US$ 375 million in 2023 and is anticipated to reach US$ 551.9 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The duck vaccines market is witnessing steady growth due to the increasing demand for duck meat and the rising prevalence of avian diseases in duck populations. Duck vaccines play a vital role in preventing and controlling viral and bacterial diseases in ducks. The market is driven by factors such as the growth of the duck farming industry, rising consumer preference for duck products, and the need for effective disease management strategies. Advancements in vaccine development and technology, such as the availability of recombinant vaccines and improved vaccination techniques, are further fueling market growth. However, challenges such as the limited availability of specific duck vaccines for certain diseases and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on improving duck health, biosecurity measures, and sustainable duck farming practices, the duck vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Duck Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duck Vaccines.
Report Scope
The Duck Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Duck Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duck Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
CEVA
CAHIC
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
Elanco
FATRO
CAVAC
Vaksindo
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Avian Influenza Vaccine
Newcastle Disease Vaccine
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Duck Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Duck Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccination is commonly used in commercial duck and increasingly in backyard birds to control disease.
The global Duck Vaccines market was valued at US$ 375 million in 2023 and is anticipated to reach US$ 551.9 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The duck vaccines market is witnessing steady growth due to the increasing demand for duck meat and the rising prevalence of avian diseases in duck populations. Duck vaccines play a vital role in preventing and controlling viral and bacterial diseases in ducks. The market is driven by factors such as the growth of the duck farming industry, rising consumer preference for duck products, and the need for effective disease management strategies. Advancements in vaccine development and technology, such as the availability of recombinant vaccines and improved vaccination techniques, are further fueling market growth. However, challenges such as the limited availability of specific duck vaccines for certain diseases and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on improving duck health, biosecurity measures, and sustainable duck farming practices, the duck vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Duck Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duck Vaccines.
Report Scope
The Duck Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Duck Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duck Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
CEVA
CAHIC
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
Elanco
FATRO
CAVAC
Vaksindo
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Avian Influenza Vaccine
Newcastle Disease Vaccine
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Duck Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Duck Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Duck Vaccines Market Overview
1.1 Product Overview and Scope of Duck Vaccines
1.2 Duck Vaccines Segment by Type
1.2.1 Global Duck Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Attenuated Live Vaccines
1.2.3 Killed Vaccines
1.3 Duck Vaccines Segment by Application
1.3.1 Global Duck Vaccines Market Value by Application: (2024-2030)
1.3.2 Avian Influenza Vaccine
1.3.3 Newcastle Disease Vaccine
1.3.4 Other
1.4 Global Duck Vaccines Market Size Estimates and Forecasts
1.4.1 Global Duck Vaccines Revenue 2019-2030
1.4.2 Global Duck Vaccines Sales 2019-2030
1.4.3 Global Duck Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Duck Vaccines Market Competition by Manufacturers
2.1 Global Duck Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Duck Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Duck Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Duck Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Duck Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Duck Vaccines, Product Type & Application
2.7 Duck Vaccines Market Competitive Situation and Trends
2.7.1 Duck Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Duck Vaccines Players Market Share by Revenue
2.7.3 Global Duck Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Duck Vaccines Retrospective Market Scenario by Region
3.1 Global Duck Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Duck Vaccines Global Duck Vaccines Sales by Region: 2019-2030
3.2.1 Global Duck Vaccines Sales by Region: 2019-2024
3.2.2 Global Duck Vaccines Sales by Region: 2025-2030
3.3 Global Duck Vaccines Global Duck Vaccines Revenue by Region: 2019-2030
3.3.1 Global Duck Vaccines Revenue by Region: 2019-2024
3.3.2 Global Duck Vaccines Revenue by Region: 2025-2030
3.4 North America Duck Vaccines Market Facts & Figures by Country
3.4.1 North America Duck Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Duck Vaccines Sales by Country (2019-2030)
3.4.3 North America Duck Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Duck Vaccines Market Facts & Figures by Country
3.5.1 Europe Duck Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Duck Vaccines Sales by Country (2019-2030)
3.5.3 Europe Duck Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Duck Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Duck Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Duck Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Duck Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Duck Vaccines Market Facts & Figures by Country
3.7.1 Latin America Duck Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Duck Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Duck Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Duck Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Duck Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Duck Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Duck Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Duck Vaccines Sales by Type (2019-2030)
4.1.1 Global Duck Vaccines Sales by Type (2019-2024)
4.1.2 Global Duck Vaccines Sales by Type (2025-2030)
4.1.3 Global Duck Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Duck Vaccines Revenue by Type (2019-2030)
4.2.1 Global Duck Vaccines Revenue by Type (2019-2024)
4.2.2 Global Duck Vaccines Revenue by Type (2025-2030)
4.2.3 Global Duck Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Duck Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Duck Vaccines Sales by Application (2019-2030)
5.1.1 Global Duck Vaccines Sales by Application (2019-2024)
5.1.2 Global Duck Vaccines Sales by Application (2025-2030)
5.1.3 Global Duck Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Duck Vaccines Revenue by Application (2019-2030)
5.2.1 Global Duck Vaccines Revenue by Application (2019-2024)
5.2.2 Global Duck Vaccines Revenue by Application (2025-2030)
5.2.3 Global Duck Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Duck Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Duck Vaccines Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Corporation Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CEVA Duck Vaccines Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Corporation Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CAHIC Duck Vaccines Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Ringpu Biology
6.4.1 Ringpu Biology Corporation Information
6.4.2 Ringpu Biology Description and Business Overview
6.4.3 Ringpu Biology Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ringpu Biology Duck Vaccines Product Portfolio
6.4.5 Ringpu Biology Recent Developments/Updates
6.5 Yebio
6.5.1 Yebio Corporation Information
6.5.2 Yebio Description and Business Overview
6.5.3 Yebio Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yebio Duck Vaccines Product Portfolio
6.5.5 Yebio Recent Developments/Updates
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Corporation Information
6.6.2 Harbin Veterinary Research Institute Description and Business Overview
6.6.3 Harbin Veterinary Research Institute Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Harbin Veterinary Research Institute Duck Vaccines Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Duck Vaccines Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zoetis Duck Vaccines Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 Elanco
6.9.1 Elanco Corporation Information
6.9.2 Elanco Description and Business Overview
6.9.3 Elanco Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Elanco Duck Vaccines Product Portfolio
6.9.5 Elanco Recent Developments/Updates
6.10 FATRO
6.10.1 FATRO Corporation Information
6.10.2 FATRO Description and Business Overview
6.10.3 FATRO Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 FATRO Duck Vaccines Product Portfolio
6.10.5 FATRO Recent Developments/Updates
6.11 CAVAC
6.11.1 CAVAC Corporation Information
6.11.2 CAVAC Duck Vaccines Description and Business Overview
6.11.3 CAVAC Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CAVAC Duck Vaccines Product Portfolio
6.11.5 CAVAC Recent Developments/Updates
6.12 Vaksindo
6.12.1 Vaksindo Corporation Information
6.12.2 Vaksindo Duck Vaccines Description and Business Overview
6.12.3 Vaksindo Duck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vaksindo Duck Vaccines Product Portfolio
6.12.5 Vaksindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Duck Vaccines Industry Chain Analysis
7.2 Duck Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Duck Vaccines Production Mode & Process
7.4 Duck Vaccines Sales and Marketing
7.4.1 Duck Vaccines Sales Channels
7.4.2 Duck Vaccines Distributors
7.5 Duck Vaccines Customers
8 Duck Vaccines Market Dynamics
8.1 Duck Vaccines Industry Trends
8.2 Duck Vaccines Market Drivers
8.3 Duck Vaccines Market Challenges
8.4 Duck Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
